Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleErlotinib overcomes paclitaxel-resistant cancer stem cells by blocking the EGFR-CREB/GRβ-IL-6 axis in MUC1-positive cervical cancer.AuthorsLv, Yaping; Cang, Wei; Li, Quanfu; Liao, Xiaodong; Zhan, Mengna; Deng, Huayun; Li, Shengze; Jin, Wei; Pang, Zhi; Qiu, Xingdi; Zhao, Kewen; Chen, Guoqiang; Qiu, Lihua; Huang, LeiPublicationOncogenesis, 2019, Vol 8, Issue 12, p1ISSN2157-9024Publication typeArticleDOI10.1038/s41389-019-0179-2